Peraltro, se sei capace di acquistare a debito selezionando con cura gli acquisti, generando sinergie e storicamente ti gestisci con un debito HY riuscendo a dare prova di affidabilità, il mercato non è necessariamente ostile alle nuove emissioni, rating o non rating.
Lo dico perché è arrivata la prima emissione HY di eurobonds dall'inizio della crisi creditizia, dopo dunque 18 mesi in cui non se ne era vista alcuna e l'emittente è tutt'altro che ignoto al comparto.
E' andata abbastanza bene, nonostante il rating HY, tant'è che l'emittente ha rivisto al rialzo i quantitativi offerti.
UPDATE 1-Fresenius ups size of euro high yield bond -source
Thu Jan 15, 2009 2:53pm GMT
* 1st European high-yield issue since credit crisis began
* Size of euro tranche increased in sign of strong demand
* Flood of European high yield bonds not expected
By Claire Milhench and Natalie Harrison
LONDON, Jan 15 (Reuters) - German healthcare group Fresenius SE increased the size of its planned high yield euro bond on Thursday, a source familiar with the deal said, in a sign of strong demand for the first issue of its kind in 18 months.
Fresenius (
FREG_p.DE) plans to sell a 275 million euro ($361.5 million) bond, raised from an initial size of 200 million, to yield 10.25 percent at the lower range of the initial 10.25 to 10.5 percent range, the source said.
"A high yield deal gets upsized. I never thought I'd see that again," said one high yield bond trader in London. But investors are not expecting a flood of other high yield bond issues to follow in the footsteps of Fresenius.
"The market will be extremely discerning," said Robin Creswell, managing principal at Payden & Rygel Global Ltd. "This isn't a gate opening saying that the high yield market is now open for business."
The two-part deal from Fresenius, described by one investor as the darling of the high yield bond market, has long been anticipated to kick-start the European junk bond market, which has been closed to new issues since July 2007 when the credit crisis was still in its early stages.
Fresenius's planned dollar bond was unchanged at $500 million and around 10.5 percent, the source said.
"It hits all the sweet points for a high yield issuance - it's a nice size, people know this company well and it's at the top of the high yield spectrum. It's also healthcare, which is relatively non-cyclical," said James Gledhill, head of fixed income at New Star Asset Management.
Creswell agreed, saying that healthcare was attractive because it was the kind of sector that was likely to benefit from government spending to stimulate the economy, and the demographics were in its favour.
"It's also a BB so it is a notch away from investment grade and the most recent rating action was an upgrade. This company can control its costs -- it needs this money to expand and grow," said Creswell.
Moody's on Monday assigned a "junk" Ba1 rating to the planned bond issue. The company's senior unsecured rating is a speculative-grade BB by both Standard & Poor's and Fitch Ratings.
TESTING THE WATER
Investors warned not to get too excited and that issuance would remain limited to solid high-yield names.
Quin Casey, a fund manager at Aviva Investors, said banks were testing the water with the Fresenius deal, assessing the strength of demand from investors.
"It's a good name to try to re-engineer some activity but at the end of the day you can't forget about what's going on in the macro picture. There's potential for more negative surprise," said Casey.
A successful Fresenius deal will not make it any easier for fallen angels -- companies that have been downgraded to "junk" status from investment-grade -- to tap the bond market, he said.
"I wouldn't say it is impossible but it will be tough for people to get comfortable with some of those names. The cost of funding for the treasurers would be substantially higher," he added.
Fresenius's planned 200 million euro bond is expected to yield 10.25 to 10.5 percent, while the yield on the $500 million bond is seen at around 10.5 percent, IFR said on Wednesday, citing market talk. Both bonds are expected to come at a discount to par.
The new bonds are priced cheaply relative to the existing bonds of Fresenius, which include a 500 million-euro bond maturing in 2013, another of the same size maturing in 2016 and a third which matures in 2011, investors said.
The spread on the new issue was estimated by investors at between 775 to 800 basis points over government bonds, compared with spreads over around 420 basis points on global power firm InterGen's [INTGN.UL] 150 million euro 10-year bond sold back in July 2007, the last high yield deal to be sold in Europe.
Deutsche Bank is the global coordinator on the deal, while JP Morgan, Credit Suisse and BNP Paribas are joint bookrunners.